Showcase of two Swiss Research Programs, 6th March (12h – 14h)
It is our pleasure to invite you to a lunch event initiated and organized by two Swiss Rare Diseases Research Programs: radiz – Rare Disease Initiative Zurich, a clinical research priority program of the University of Zurich and Â«Rare Diseases â€“ New ApproachesÂ» an initiative of Gebert RĂĽf Stiftung (GRS).
Learn about the research programs by attending the presentation of short pitches followed by a networking lunch.
Matthias Geering, Head Communication & Marketing, University of Basel
- Prof. Dr. Matthias Baumgartner, University Childrenâ€™s Hospital Zurich, University of Zurich, lead radiz (radiz):Â Methylmalonic aciduria â€“ from pathophysiology towards novel therapies
- PD Dr. Thorsten Hornemann, University Hospital Zurich (radiz):Â Atypical sphingolipids as therapeutic targets in rare diseases
- Prof. Dr. Jeffrey Hubbell, Ecole Polytechnique FĂ©dĂ©rale de Lausanne (GRS): Tolerance Induction to Protein Drugs Through Erythrocyte Binding
- Prof. Dr. Barbara Plecko, University Childrenâ€™s Hospital Zurich, University of Zurich (radiz):Â A combined metabolic-genetic approach to unravel causes of epileptic encephalopathies of childhood (together with Prof. Rauch)
- Prof. Dr. Anita Rauch, University of Zurich (radiz):Â A combined metabolic-genetic approach to unravel causes of epileptic encephalopathies of childhood (together with Prof. Plecko)
- PD Dr. Janine Reichenbach, University Childrenâ€™s Hospital Zurich (GRS): Role of Macroautophagy in Chronic Granulomatous Disease and Correction of the Defect
- Prof. Dr. Botond Roska, Friedrich Miescher Insitute for Biomedical Research (GRS): Optogenic Vision Restoration
- Prof. Dr. Didier Trono, Ecole Polytechnique FĂ©dĂ©rale de Lausanne (GRS): Diseases of Imprinting
- Prof. Dr. Gisou van der Goot, Ecole Polytechnique FĂ©dĂ©rale de Lausanne (GRS): Towards Preventing Nodule Formation in Hyaline Fibormatosis Patients
Gehry Building, Small Auditorium, Level -3
Please register for the congress and mark the lunch event during the registration process. Number of participants is limited to 100.
radiz â€“ the Rare Disease Initiative Zurich is a clinical research priority program of the University of Zurich. radiz is a joint effort of the University Childrenâ€™s Hospital Zurich, the University of Zurich, and the University Hospital Zurich in the fight against rare diseases. By building a strong interdisciplinary network of researchers and clinicians focused on rare diseases in Zurich, radiz aims to bridge the gap between basic and clinical research in rare diseases. Several translational rare disease research projects are being funded by radiz. Continuing education is being offered in order to raise awareness for rare diseases among physicians, researchers, and the general public.
Rare Diseases â€“ New Approaches
Gebert RĂĽf Stiftung is a private Swiss science foundation, active in various fields of innovation. Since 2009 it runs the program Â«Rare Diseases â€“ New ApproachesÂ» based on annual calls. The program aims at developing and implementing innovative technologies or approaches in the diagnosis and treatment of rare diseases. 2 million Swiss Francs are invested annually; 21 projects out of 192 applications have been financed.